Get started
Author

Gugu N. Mahlangu

Observed names: G. N. Mahlangu, Gugu Mahlangu, Gugu N Mahlangu, Mahlangu, Gugu
ORCID: 0000-0002-3435-5577
Observed ORCID: 0000-0002-3435-5577
OpenAlex ID: A5013184220
Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems
2018 · Lukas Roth, Daniel Bempong, et al. · Globalization and Health · 118
PDF
Evaluating the Success of ZaZiBoNa, the Southern African Development Community Collaborative Medicines Registration Initiative
2020 · Tariro Sithole, Gugu Mahlangu, et al. · Therapeutic Innovation & Regulatory Science · 40
PDF
Needs‐driven talent and competency development for the next generation of regulatory scientists in Africa
2021 · Boitumelo Semete‐Makokotlela, Gugu N. Mahlangu, et al. · British Journal of Clinical Pharmacology · 33
PDF
Understanding Quality Paradigm Shifts in the Evolving Pharmaceutical Landscape: Perspectives from the USP Quality Advisory Group
2021 · Jane Weitzel, Horacio Pappa, et al. · The AAPS Journal · 27
PDF
Evaluation of the Regulatory Review Process in Zimbabwe: Challenges and Opportunities
2021 · Tariro Sithole, Gugu Mahlangu, et al. · Therapeutic Innovation & Regulatory Science · 24
PDF
A rapid assessment of the National Regulatory Systems for medical products in the Southern African Development Community
2020 · S. Dube-Mwedzi, S. Kniazkov, et al. · Journal of Pharmaceutical Policy and Practice · 20
PDF
A new approach to an old problem: Overview of the East African Community’s Medicines Regulatory Harmonization initiative
2020 · Margareth Ndomondo-Sigonda, Gugu Mahlangu, et al. · PLoS Medicine · 19
PDF
Evaluation of the Good Review Practices of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward
2021 · Tariro Sithole, Gugu Mahlangu, et al. · Frontiers in Medicine · 17
PDF
Global regulatory agility during covid-19 and other health emergencies
2020 · Tippi K Mak, John CW Lim, et al. · BMJ · 16
Regulatory Authority Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward
2022 · Tariro Sithole, Gugu Mahlangu, et al. · Frontiers in Medicine · 14
Evaluation of the Review Models and Approval Timelines of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward
2021 · Tariro Sithole, Gugu Mahlangu, et al. · Frontiers in Medicine · 13
Comparison of the registration process of the medicines control authority of Zimbabwe with Australia, Canada, Singapore, and Switzerland: benchmarking best practices
2021 · Tariro Sithole, Sam Salek, et al. · Expert Review of Clinical Pharmacology · 11
PDF
Pharmaceutical Industry Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward
2022 · Tariro Sithole, Gugu Mahlangu, et al. · Frontiers in Medicine · 9
Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries
2023 · Ambrose O. Isah, Abimbola O. Opadeyi, et al. · Therapeutic Advances in Drug Safety · 7
Strengthening Vaccine Safety Systems, Research, and Regional Collaboration in Africa: A Call to Action
2025 · Beckie N. Tagbo, Chioma S. Ejekam, et al. · Vaccines · 2
PDF
Comparison of the registration process of the medicines control authority of Zimbabwe with Australia, Canada, Singapore, and Switzerland: benchmarking best practices
2021 · Sithole, Tariro, Salek, Sam, et al. · Figshare
Works count: 16
Citation count: 370
H-index: 11
I10-index: 12
Year
Topic
Type